EN
DE
Home
About us
Biofronteras Expertise
Management and supervisory board
Product Pipeline
Clinical trials
Products
Product Portfolio
Investors & Media
Key stock information
Financial reports
Financial announcements
Shareholder structure
Corporate calendar
Corporate governance
Annual general meeting
Presentations & contact
Career
Careers
Contact
Biofrontera
Investors & Media
Financial announcements
Latest News Releases
10/23/2025 16:50
PTA-News: Biofrontera AG: Biofrontera AG completes sale of U.S. Ameluz® and RhodoLED® assets to Biofrontera Inc.
09/30/2025 22:48
PTA-News: Biofrontera AG: Correction notice regarding the H1 2025 report and the corresponding press release dated September 30, 2025, 00:18 a.m.
09/30/2025 20:15
PTA-News: Biofrontera AG: Biofrontera AG: BIOFRONTERA REPORTS RESULTS FOR THE FIRST HALF OF 2025
09/30/2025 00:22
PTA-News: Biofrontera AG: BIOFRONTERA REPORTS RESULTS FOR THE FIRST HALF OF 2025
09/24/2025 23:10
PTA-Adhoc: Biofrontera AG: Expected impairment losses
08/01/2025 12:05
PTA-Adhoc: Biofrontera AG: Biofrontera AG: New Forecast
07/01/2025 01:40
PTA-Adhoc: Biofrontera AG: Biofrontera Inc. Fulfills the conditions for implementing the term sheet with Biofrontera AG
06/30/2025 14:15
PTA-News: Biofrontera AG: Secures Long-Term U.S. Market Presence Through Strategic Restructuring Agreement with Biofrontera Inc.
06/30/2025 14:00
PTA-Adhoc: Biofrontera AG: Agreement with Biofrontera Inc. about cooperation in the future
06/26/2025 20:40
PTA-Adhoc: Biofrontera AG: EXTENSION OF BIOFRONTERA INC. PAYMENT DEFERRAL - UPDATE
Financial announcements
Financial announcements
Material News
Current & Archive (Related Party Transactions incl.)
Corporate News
Current & Archive
Voting Rights
Notifications
Current & Archive
Directors' Dealings
Current & Archive
